Ian C Ashurst

Title: The Innovative Contributions of Ian C Ashurst

Introduction

Ian C Ashurst is a notable inventor based in Ware, GB, recognized for his significant contributions to the field of inhalation drug delivery systems. With a total of seven patents to his name, Ashurst has made strides in developing metered dose inhalers that enhance the efficacy of respiratory medications.

Latest Patents

Among his latest innovations are two key patents for metered dose inhalers. The first patent focuses on a metered dose inhaler for fluticasone propionate, which features internal surfaces coated with fluorocarbon polymers. This design optimally combines these polymers with non-fluorocarbon polymers to dispense an inhalation drug formulation that includes albuterol or its physiologically acceptable salts, utilizing a fluorocarbon propellant. The second patent is for a metered dose inhaler for albuterol, which similarly incorporates fluorocarbon and non-fluorocarbon polymers to deliver fluticasone propionate or its acceptable solvates, also using a fluorocarbon propellant.

Career Highlights

Ian C Ashurst has had a distinguished career, having worked with prominent companies such as SmithKline Beecham Corporation and Glaxo Wellcome Inc. His work in these organizations has contributed to advancements in pharmaceutical technology, particularly in the area of inhalation therapies.

Collaborations

Throughout his career, Ashurst has collaborated with notable professionals in the field, including Craig Steven Herman and Michael Thomas Riebe. These collaborations have further enriched his work and contributed to the development of innovative solutions in drug delivery.

Conclusion

Ian C Ashurst's contributions to the field of inhalation drug delivery are significant and impactful. His innovative patents and collaborations reflect his dedication to improving respiratory therapies. His work continues to influence the pharmaceutical industry and enhance patient care.